Search
for
Sort by
Research 361–390 of 1000+
- The Use of Light‐Based Therapies in the Treatment of Alopecia
- Reviving Hair Naturally: An Ayurvedic Case Report on Indralupta (Alopecia)
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Trichoscopy – a valuable tool for identifying conditions mimicking androgenetic alopecia
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- “Downy hair sign”—A clue to autoimmune disease in curly hair
- The role of laser and energy-assisted drug delivery in the treatment of alopecia
- Introductory Chapter: Alopecia Management – An Update
- SnapshotDx Quiz: May 2022
- A Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Anti-Skin-Aging Effect of LactoSporin – The Extracellular Metabolite from Bacillus coagulans (Weizmannia coagulans) MTCC 5856 in Healthy Female Volunteers
- Revitalizing skin, hair, nails, and muscles: Unlocking beauty and wellness with vegan collagen
- Efficacy and Safety of Skin Radiance Collagen on Skin and Hair Matrix: A Placebo-Controlled Clinical Trial in Healthy Human Subjects
- The JAK/STAT signaling pathway: from bench to clinic
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Vitamin D and the Skin: An Update for Dermatologists
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Insulin Resistance and Skin Diseases
- The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients
- The Human Skin Microbiome in Selected Cutaneous Diseases
- Pathomechanisms of immune-mediated alopecia
- The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review
- The influence of interferon on healthy and diseased skin
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Implication of Human Bacterial Gut Microbiota on Immune-Mediated and Autoimmune Dermatological Diseases and Their Comorbidities: A Narrative Review